1. Home
  2. SERA vs STIM Comparison

SERA vs STIM Comparison

Compare SERA & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

HOLD

Current Price

$2.02

Market Cap

75.2M

Sector

Health Care

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.39

Market Cap

88.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SERA
STIM
Founded
2008
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.2M
88.4M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
SERA
STIM
Price
$2.02
$1.39
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
40.4K
1.3M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
32.32
57.25
EPS
N/A
N/A
Revenue
$81,000.00
$52,776,000.00
Revenue This Year
$554.81
$11.10
Revenue Next Year
$517.27
$11.92
P/E Ratio
N/A
N/A
Revenue Growth
5.19
N/A
52 Week Low
$1.56
$0.80
52 Week High
$3.95
$4.84

Technical Indicators

Market Signals
Indicator
SERA
STIM
Relative Strength Index (RSI) 54.72 55.17
Support Level $1.85 $1.21
Resistance Level $2.03 $1.42
Average True Range (ATR) 0.14 0.11
MACD 0.01 0.02
Stochastic Oscillator 75.34 61.54

Price Performance

Historical Comparison
SERA
STIM

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: